الفهرس 
Introduction & Aim of the workOnly 14 pages are availabe for public view
 |  | from | 120 |  |  |
| | | from | 120 | | |
Abstract
Endovascular therapy is increasingly becoming a first-line
treatment option for patients suffering from critical limb ischemia
from infrapopliteal arterial occlusive disease by easily revascularizing
inflow and outflow lesions with minimal morbidity and mortality. It
has the ability to significantly improve distal extremity perfusion
pressure with high technical success rates.
Peripheral arterial disease (PAD) is a progressive chronic
debilitating disease which is prevalent in diabetic elder people.
Critical limb ischaemia (CLI) is severe form of PAD with a high risk
of major amputation, disability and death.
This study was designed to assess the following:
1. To assess the effect of tibial angioplasty in the management ofinfrapopliteal
arterial disease in 20 diabetic patient within six months.
2. To assess the effect of medical treatment in the management of
infra-popliteal arterial disease in 20 diabetic patient within six
months.
3. To detect the percentage of successful angioplasty managementof
cases with infra-popliteal arterial disease and diabetes.
4. To detect the percentage of success of medical treatment of cases
with infra-popliteal arterial disease and diabetes.
5. To discuss complications, morbidity and mortality of cases
withinfra-popliteal arterial disease and diabetes after angioplasty.
6. This study included 20 patients who underwent PTA for
infrapoplitealarterial occlusive disease (group A). The indications
forintervention were rest pain, tissue loss or gangrene (critical
limbischemia). According to the Trans-Atlantic Inter-Society
Consensus(TASC) classification, 9 patients were within criteria of
TASC groupC, 11 patients were within criteria of TASC group
D.and anther group (B) undergo medical treatment.